Document:

Exhibit 4.20

 

July 29, 2015

 

 

To the Purchasers Listed

On Schedule A hereto

 

 

Dear Purchasers:

 

In connection with
that certain Securities Purchase Agreement, dated as of July 24, 2015 (as it may be amended from time to time, the “Purchase
Agreement”), by and among Amyris, Inc., a Delaware corporation (the “Company”), and the
purchasers listed on Schedule I thereto (each, a “Purchaser”, and collectively, the “Purchasers”)
and that certain Amended and Restated Investors’ Rights Agreement dated as of June 21, 2010, as amended by (i) Amendment
No. 1 to Amended and Restated Investors’ Rights Agreement, dated as of February 23, 2012, (ii) Amendment No. 2 to Amended
and Restated Investors’ Rights Agreement, dated as of December 24, 2012, (iii) Amendment No. 3 to Amended and Restated Investors’
Rights Agreement, dated as of March 27, 2013, (iv) Amendment No. 4 to Amended and Restated Investors’ Rights Agreement, dated
as of October 16, 2013, (v) Amendment No. 5 to Amended and Restated Investors’ Rights Agreement, dated as of December 24,
2013 and (vi) Amendment No. 6 to Amended and Restated Investors’ Rights Agreement, dated as of July 26, 2015 (as amended,
the “Rights Agreement”), by and among the Company and certain of its stockholders party thereto, the
Company and the Purchasers are entering into this Letter Agreement. Capitalized terms used herein but not otherwise defined shall
have the meaning given to such terms in the Rights Agreement.

The Company and the
undersigned Purchasers agree to the following:

 

1.                 
Definitions. As used in this Letter Agreement, the following terms shall have the following meanings:

 

		a.	“Effectiveness Period” means the earlier of (i) such time as all of the
Registrable Securities covered by the Registration Statement have been publicly sold by the Purchasers or (ii) the date that all
Registrable Securities covered by the Registration Statement may be sold by non-affiliates without volume or manner-of-sale restrictions
pursuant to Rule 144, without the requirement for the Company to be in compliance with the current public information requirement
under Rule 144 as determined by counsel to the Company pursuant to a written opinion letter to such effect, addressed and
reasonably acceptable to the Company’s transfer agent.

 

		b.	“Prospectus” means the prospectus included in the Registration Statement
(including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of
an effective registration statement in reliance upon Rule 430A promulgated under the Act), as amended or supplemented by any prospectus
supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by the Registration

 

    	 

    	 

    

Statement, and
all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference
or deemed to be incorporated by reference in such Prospectus.

 

		c.	“Rule 144” means Rule 144 promulgated by the SEC pursuant to the Act,
as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially
the same effect as such Rule.

 

		d.	“SEC Guidance” means (i) any publicly-available written or oral guidance,
comments, requirements or requests of the SEC staff and (ii) the Act.

 

2.                 
Registration. The Company hereby agrees to file a registration statement on Form S-3 under the Act (the “Registration
Statement”) covering the shares of the Company’s Common Stock that may become issuable upon exercise of any warrants
contemplated by the Purchase Agreement (the “Warrant Shares”) and the shares of Common Stock sold and issued pursuant
to the Purchase Agreement (such Warrant Shares and shares of Common Stock, the “Registrable Securities”) as soon as
practicable and in no event later than thirty (30) calendar days following the date hereof (the “Filing Deadline”);
provided, however, that if the Filing Deadline falls on a Saturday, Sunday or other day that the SEC is closed for business, the
Filing Deadline shall be extended to the next business day. The Company shall use its commercially reasonable efforts to cause
the Registration Statement to be declared effective by the SEC as soon as practicable and no later than the ninetieth (90th) day
following the filing of the Registration Statement (or, in the event the SEC reviews and has written comments to the Registration
Statement, the one hundred twentieth (120th) calendar day following the filing of the Registration Statement) (the “Effectiveness
Deadline”); provided, however, that if the Effectiveness Deadline falls on a Saturday, Sunday or other day that the SEC is
closed for business, the Effectiveness Deadline shall be extended to the next business day.

 

3.                 
Applicable Provisions. The provisions of Sections 1.4, 1.5, 1.6, 1.9, 1.10 and 1.11 of the Rights Agreement are hereby
incorporated by reference, mutatis mutandis, and shall be deemed to be a part hereof as if restated herein in their entirety; provided,
however, that for purposes of this Letter Agreement the references in Section 1.4(a) of the Rights Agreement to “one hundred
twenty (120) days” and “120-day period” shall be deemed to be “one (1) year” and “1-year period,”
respectively.

 

4.                 
Representations. The Company hereby represents and warrants to each of the Purchasers that this Letter Agreement
and the Rights Agreement are the only agreements pursuant to which registration rights exist in respect of the Registrable Securities.

 

5.                 
Liquidated Damages. If: (i) the Registration Statement is not filed with the SEC on or prior to the Filing Deadline,
(ii) the Registration Statement is not declared effective by the SEC (or otherwise does not become effective) for any reason on
or prior to the later of (x) the Effectiveness Deadline or (y) the date which SEC Guidance permits the Registration Statement to
be declared effective, (iii) after the effective date of the Registration Statement, (A) the Registration Statement ceases for
any reason (including without limitation by reason of a stop order, or the Company’s failure to update the Registration Statement),
to remain continuously effective as to all Registrable Securities included in such Registration Statement or (B) the

 

    	2

    	 

    

Purchasers are not permitted
to utilize the Prospectus therein to resell the Registrable Securities for any reason for more than an aggregate of twenty (20)
consecutive calendar days or forty (40) calendar days (which need not be consecutive days) during any twelve (12) month period,
or (iv) the Company fails to satisfy the current public information requirement pursuant to Rule 144(c)(1) as a result of which
the Purchasers who are not affiliates are unable to sell the Registrable Securities without restriction under Rule 144 (or any
successor thereto), (any such failure or breach in clauses (i) through (iv) above being referred to as an “Event,”
and, for purposes of clauses (i), (ii) or (iv), the date on which such Event occurs, or for purposes of clause (iii), the date
on which such twenty (20) or forty (40) calendar day period is exceeded, being referred to as an “Event Date”), then
in addition to any other rights the Purchasers may have hereunder or under applicable law, on each such Event Date and on each
30-day anniversary (or pro rata portion thereof) of each such Event Date (if the applicable Event shall not have been cured by
such date) until the earlier of (1) the applicable Event is cured or (2) the Registrable Securities are eligible for resale
pursuant to Rule 144 without manner of sale or volume restrictions, the Company shall pay to each Purchaser an amount in cash,
as partial liquidated damages and not as a penalty (“Liquidated Damages”), equal (x) on the Event Date and through
the fifth 30-day anniversary thereafter, one-half percent (0.5%) of the aggregate purchase price paid by such Purchaser pursuant
to the Purchase Agreement for the Securities (as defined in the Purchase Agreement) with respect to which any unregistered Registrable
Securities are then held by such Purchaser or would be held by such Purchaser if the Securities held by such Purchaser were converted,
and (y) from the sixth 30-day anniversary of the Event Date and thereafter, one percent (1.0%) of the aggregate purchase price
paid by such Purchaser pursuant to the Purchase Agreement for the Securities with respect to which any unregistered Registrable
Securities are then held by such Purchaser or would be held by such Purchaser if the Securities held by such Purchaser were converted.
The parties agree that (1) notwithstanding anything to the contrary herein or in the Purchase Agreement, no Liquidated Damages
shall be payable with respect to any period after the expiration of the Effectiveness Period (except in respect of an Event described
in clause (iv) above), (it being understood that this sentence shall not relieve the Company of any Liquidated Damages accruing
prior to the Effectiveness Deadline) and in no event shall the aggregate amount of Liquidated Damages (excluding Liquidated Damages
payable in respect of an Event described in clause (iv) above) payable to a Purchaser exceed, in the aggregate, ten percent (10%)
of the aggregate purchase price paid by such Purchaser pursuant to the Purchase Agreement (or twelve percent (12%) if the only
Event is clause (iv)) and (2) in no event shall the Company be liable in any thirty (30) day period for Liquidated Damages under
this Agreement in excess of, (x) with respect to the first five 30-day anniversaries after the Event Date, and including the Event
Date, one-half percent (0.5%) of the aggregate purchase price paid by the Purchasers pursuant to the Purchase Agreement, and (y)
with respect to the sixth 30-day anniversary and any date thereafter, one percent (1.0%) of the aggregate purchase price paid by
the Purchasers pursuant to the Purchase Agreement. If the Company fails to pay any Liquidated Damages pursuant to this Section
5 in full within five (5) business days after the date payable, the Company will pay interest thereon at a rate of one and one-half
percent (1.5%) per month (or such lesser maximum amount that is permitted to be paid by applicable law) to the Purchaser, accruing
daily from the date such Liquidated Damages are due until such amounts, plus all such interest thereon, are paid in full. The Liquidated
Damages pursuant to the terms hereof shall apply on a daily pro-rata basis for any portion of a month prior to the cure of an Event.
Notwithstanding the foregoing, nothing shall preclude any Purchaser from pursuing or obtaining

 

    	3

    	 

    

any available remedies
at law, specific performance or other equitable relief with respect to this Section 5 in accordance with applicable law. In
such case, the Liquidated Damages shall be calculated to only apply to the percentage of Registrable Securities which are permitted
in accordance with SEC Guidance to be included in the Registration Statement. The Effectiveness Deadline for the Registration Statement
shall be extended without default or Liquidated Damages hereunder in the event that the Company’s failure to obtain the effectiveness
of the Registration Statement on a timely basis results from the failure of a Purchaser to timely provide the Company with
information requested by the Company and necessary to complete the Registration Statement in accordance with the requirements of
the Act (in which the Effectiveness Deadline would be extended with respect to Registrable Securities held by such Purchaser).

 

6.                 
Amendment and Waiver.      No amendment, modification, termination or cancellation
of this Letter Agreement shall be effective unless it is in writing signed by the Company and each of the Purchasers party hereto.
No waiver of any of the provisions of this Letter Agreement shall be deemed or shall constitute a waiver of any other provisions
hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.

 

7.                 
Entire Agreement.    This Letter Agreement, the Purchase Agreement, the Rights Agreement and
the agreements contemplated thereby set forth the entire understanding between the parties hereto relating to the subject matter
hereof and supersedes and merges all previous written and oral negotiations, commitments, understandings and agreements relating
to the subject matter hereof between the Company and the Purchasers.

 

8.                 
Assignment.    This Letter Agreement may be transferred or assigned in accordance with Section
1.13 of the Rights Agreement.

 

9.                 
Notices.    All notices, requests, and other communications hereunder shall be in writing and
will be deemed to have been duly given and received (a) when personally delivered, (b) when sent by facsimile upon confirmation
of receipt, (c) one business day after the day on which the same has been delivered prepaid to a nationally recognized courier
service, or (d) five business days after the deposit in the United States mail, registered or certified, return receipt requested,
postage prepaid, in each case addressed, as to the Company, to Amyris, Inc., 5885 Hollis Street, Suite 100, Emeryville, CA 94608,
Attn: General Counsel, with a copy to Fenwick & West LLP, 801 California Street, Mountain View, CA 94041, Attn: Dan Winnike,
Esq., and as to the Purchaser at the address and facsimile number set forth below the Purchaser’s signature on the signature
pages of this Letter Agreement. Any party hereto from time to time may change its address, facsimile number, or other information
for the purpose of notices to that party by giving notice specifying such change to the other parties hereto. Each Purchaser and
the Company may each agree in writing to accept notices and other communications to it hereunder by electronic communications pursuant
to procedures reasonably approved by it; provided that approval of such procedures may be limited to particular notices or communications.

 

10.                 
Governing
Law.

 

    	4

    	 

    

		a.	This Letter Agreement shall be governed by and construed in accordance with the laws of the State
of Delaware applicable to contracts entered into therein, without reference to principles of choice of law or conflicts of laws
that might lead to the application of laws other than the laws of the State of Delaware.

 

		b.	Any and all disputes arising out of, or in connection with, the interpretation, performance, or
nonperformance of this Letter Agreement or any and all disputes arising out of, or in connection with, transactions in any way
related to this Letter Agreement and/or the relationship between the parties shall be resolved pursuant to Section 8.6 of the Purchase
Agreement.

 

11.             
Counterparts. This Letter Agreement may be executed in one or more counterparts, which shall together constitute
one agreement.

 

Please indicate your
agreement to the terms of this Letter Agreement by executing the acknowledgement and agreement below and returning a copy to the
attention of Nicholas Khadder, our General Counsel.

 

[Remainder of Page Intentionally Left Blank]

 

 

 

 

    	5

    	 

    

 

	 	Very truly yours,
	 	AMYRIS, INC.
	 	 
	 	 
	 	/s/ John G. Melo
	 	Name: John G. Melo
	 	Title: President and Chief Executive Officer

 

 

 

 

 

 

 

 

    	[Signature Page to Registration Rights Letter Agreement]

    	 

    

	 	Acknowledged and Agreed as
	 	of the date first written above:
	 	 	 	 	 
	 	PURCHASERS:
	 	 
	 	 	 	 	FORIS VENTURES, LLC
	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	/s/
        Barbara Hager
	 	 	 	 	(signature)
	 	 	 	 	 
	 	 	Name:	 	Barbara
        Hager
	 	 	 	 	(printed name)
	 	 	 	 	 
	 	 	Title:	 	Manager
	 	 	 	 	 
	 	 	 	 	 
	 	 	Address:	 	 
	 	 	 	 	 
	 	 	Facsimile No:	 	 
	 	 	 	 	 
	 	 	E-mail Address:	 	 

 

 

 

 

 

    	[Signature Page to Registration Rights Letter Agreement]

    	 

    
	 	Acknowledged and Agreed as
	 	of the date first written above:
	 	 	 	 	 
	 	PURCHASERS:
	 	 
	 	 	 	 	WOLVERINE FLAGSHIP FUND TRADING LIMITED
	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	/s/
        Andrew R. Sujdak
	 	 	 	 	(signature)
	 	 	 	 	 
	 	 	Name:	 	Andrew
        R. Sujdak
	 	 	 	 	(printed name)
	 	 	 	 	 
	 	 	Title:	 	Authorized Signatory
	 	 	 	 	 
	 	 	 	 	 
	 	 	Address:	 	 
	 	 	 	 	 
	 	 	Facsimile No:	 	 
	 	 	 	 	 
	 	 	E-mail Address:	 	 

 

 

 

 

 

    	[Signature Page to Registration Rights Letter Agreement]

    	 

    

	 	Acknowledged and Agreed as
	 	of the date first written above:
	 	 	 	 	 
	 	PURCHASERS:
	 	 
	 	 	 	 	NOMIS BAY LTD.
	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	/s/
        ILLEGIBLE
	 	 	 	 	(signature)
	 	 	 	 	 
	 	 	Name:	 	 
	 	 	 	 	(printed name)
	 	 	 	 	 
	 	 	Title:	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	Address:	 	 
	 	 	 	 	 
	 	 	Facsimile No:	 	 
	 	 	 	 	 
	 	 	E-mail Address:	 	 

 

 

 

 

 

    	[Signature Page to Registration Rights Letter Agreement]

    	 

    

	 	Acknowledged and Agreed as
	 	of the date first written above:
	 	 	 	 	 
	 	PURCHASERS:
	 	 
	 	 	 	 	TOTAL ENERGIES NOUVELLES ACTIVITÉS USA
	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	/s/
        Bernard Clement
	 	 	 	 	(signature)
	 	 	 	 	 
	 	 	Name:	 	Bernard
        Clement
	 	 	 	 	(printed name)
	 	 	 	 	 
	 	 	Title:	 	President
	 	 	 	 	 
	 	 	 	 	 
	 	 	Address:	 	 
	 	 	 	 	 
	 	 	Facsimile No:	 	 
	 	 	 	 	 
	 	 	E-mail Address:	 	 

 

 

 

 

 

    	[Signature Page to Registration Rights Letter Agreement]

    	 

    
	 	Acknowledged and Agreed as
	 	of the date first written above:
	 	 	 	 	 
	 	PURCHASERS:
	 	 
	 	 	 	 	CONNECTIVE CAPITAL I MASTER FUND, LTD
	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	/s/
        Robert Romero
	 	 	 	 	(signature)
	 	 	 	 	 
	 	 	Name:	 	Robert
        Romero
	 	 	 	 	(printed name)
	 	 	 	 	 
	 	 	Title:	 	Director
	 	 	 	 	 
	 	 	 	 	 
	 	 	Address:	 	 
	 	 	 	 	 
	 	 	Facsimile No:	 	 
	 	 	 	 	 
	 	 	E-mail Address:	 	 

 

 

 

 

 

    	[Signature Page to Registration Rights Letter Agreement]

    	 

    
	 	Acknowledged and Agreed as
	 	of the date first written above:
	 	 	 	 	 
	 	PURCHASERS:
	 	 
	 	 	 	 	CONNECTIVE CAPITAL I EMERGING ENERGY QP, LP
	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	/s/
        Robert Romero
	 	 	 	 	(signature)
	 	 	 	 	 
	 	 	Name:	 	Robert
        Romero
	 	 	 	 	(printed name)
	 	 	 	 	 
	 	 	Title:	 	Managing Member
	 	 	 	 	 
	 	 	 	 	 
	 	 	Address:	 	 
	 	 	 	 	 
	 	 	Facsimile No:	 	 
	 	 	 	 	 
	 	 	E-mail Address:	 	 

 

 

 

 

 

    	[Signature Page to Registration Rights Letter Agreement]

    	 

    
    	 	Acknowledged and Agreed as
	 	of the date first written above:
	 	 	 	 	 
	 	PURCHASERS:
	 	 
	 	 	 	 	NAXYRIS S.A.
	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	 	/s/
        Jacques Reckinger
	 	 	 	 	(signature)
	 	 	 	 	 
	 	 	Name:	 	Jacques
        Reckinger
	 	 	 	 	(printed name)
	 	 	 	 	 
	 	 	Title:	 	Director
	 	 	 	 	 
	 	 	By:	 	/s/
        Christoph Piel
	 	 	 	 	 
	 	 	Name:	 	Christoph
        PIEL
	 	 	 	 	 
	 	 	Title:	 	Director
	 	 	 	 	 
	 	 	 	 	 
	 	 	Address:	 	 
	 	 	 	 	 
	 	 	Facsimile No:	 	 
	 	 	 	 	 
	 	 	E-mail Address:	 	 

 

 

 

 

 

    	[Signature Page to Registration Rights Letter Agreement]

    	 

    

Schedule A

 

	Purchaser
	Foris Ventures, LLC
	Wolverine Flagship Fund Trading Limited
	Nomis Bay, Ltd.
	Total Energies Nouvelles Activités USA
	Connective Capital I Master Fund, LTD 
	Connective Capital Emerging Energy QP, LP
	Naxyris S.A.Exhibit 4.21

 

NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (the “SeCURITIES ACT”), OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF
REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR
(II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY
BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

WARRANT TO PURCHASE STOCK

 

 

	Company:	 	Amyris, Inc., a Delaware corporation 
	Warrant Certificate:	 	W-
	Number of Shares:	 	 
	Class of Stock:	 	Common
Stock
	Warrant Price:	 	$0.01 per
share
	Issue Date:	 	July 29, 2015
	Expiration Date:	 	The 5th
anniversary after the Issue Date

 

THIS WARRANT CERTIFIES
THAT, for good and valuable consideration, [INSERT INVESTOR NAME] (together with
any registered holder from time to time of this Warrant or any holder of the shares issuable or issued upon exercise of this Warrant
“Holder”) is entitled to purchase the number of fully paid and nonassessable shares of the class of securities (the
“Shares”) of the Company at the Warrant Price, all as set forth above and as adjusted pursuant to Article 2 of this
Warrant, subject to the provisions and upon the terms and conditions set forth in this Warrant. Capitalized terms used but not
otherwise defined herein shall have the meaning ascribed to them in the Purchase Agreement. This Warrant is issued in connection
with the Securities Purchase Agreement between Company and the Purchasers (as defined therein) dated as of July 23, 2015, as amended
from time to time (the “Purchase Agreement”).

 

Article
1.    EXERCISE.

 

1.1.           
Conditions to Exercise. Holder may not exercise this Warrant unless and until
this Warrant has been approved by a majority of the Company’s stockholders whose vote was counted at the Stockholders
Meeting (the “Exercise Condition”). Upon satisfaction of the Exercise Condition and thereafter, this Warrant shall
be exercisable for              shares of the Company’s Common
Stock (subject to adjustment as provided herein) (the “Shares”). The number of shares and the Warrant Price are subject
to adjustment as provided herein, and all references to “Shares” and “Warrant Price” herein shall be deemed
to include any such adjustment or series of adjustments.

    	 

    	 

    

1.2.           
Method of Exercise. 

 

(a)               
Mechanics. This Warrant may be exercised by the Holder on any day on or after the date the Exercise Condition
has been satisfied (an “Exercise Date”), in whole or in part, by delivery (whether via facsimile or otherwise)
of a written notice, in the form attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s
election to exercise this Warrant. Within one (1) Trading Day following an exercise of this Warrant as aforesaid, the Holder shall
deliver payment to the Company of an amount equal to the Exercise Price in effect on the date of such exercise multiplied by the
number of Shares as to which this Warrant was so exercised (the “Aggregate Exercise Price”) in cash or via wire transfer
of immediately available funds if the Holder did not notify the Company in such Exercise Notice that such exercise was made pursuant
to a Cashless Exercise (as defined in Section 1.3). The Holder shall not be required to deliver the original of this Warrant in
order to effect an exercise hereunder. Execution and delivery of an Exercise Notice with respect to less than all of the Shares
shall have the same effect as cancellation of the original of this Warrant and issuance of a new Warrant evidencing the right to
purchase the remaining number of Shares. Execution and delivery of an Exercise Notice for all of the then-remaining Shares shall
have the same effect as cancellation of the original of this Warrant after delivery of the Shares in accordance with the terms
hereof. On or before the third (3rd) Trading Day following the date on which the Company has received such Exercise Notice, the
Company shall (X) provided that the Transfer Agent is participating in The Depository Trust Company (“DTC”)
Fast Automated Securities Transfer Program, upon the request of the Holder, credit such aggregate number of shares of Common Stock
to which the Holder is entitled pursuant to such exercise to the Holder’s or its designee’s balance account with DTC
through its Deposit/Withdrawal at Custodian system, or (Y) if the Transfer Agent is not participating in the DTC Fast Automated
Securities Transfer Program, upon the request of the Holder, issue and deliver (via reputable overnight courier) to the address
as specified in the Exercise Notice, a certificate, registered in the name of the Holder or its designee, for the number of shares
of Common Stock to which the Holder shall be entitled pursuant to such exercise. Upon delivery of an Exercise Notice, the Holder
shall be deemed for all corporate purposes to have become the holder of record of the Shares with respect to which this Warrant
has been exercised, irrespective of the date such Shares are credited to the Holder’s DTC account or the date of delivery
of the certificates evidencing such Shares (as the case may be). If this Warrant is submitted in connection with any exercise pursuant
to this Section 1 and the number of Shares represented by this Warrant submitted for exercise is greater than the number of Shares
being acquired upon an exercise and upon surrender of this Warrant to the Company by the Holder, then, at the request of the Holder,
the Company shall as soon as practicable and in no event later than three (3) Business Days after any exercise and at its own expense,
issue and deliver to the Holder (or its designee) a new Warrant representing the right to purchase the number of Shares purchasable
immediately prior to such exercise under this Warrant, less the number of Shares with respect to which this Warrant is exercised.
No fractional shares of Common Stock are to be issued upon the exercise of this Warrant, but rather the number of shares of Common
Stock to be issued shall be rounded down to the nearest whole number. The Company shall pay any and all transfer, stamp, issuance
and similar taxes, costs and expenses (including, without limitation, fees and expenses of the Transfer Agent) that may be payable
with respect to the issuance and delivery of Shares upon exercise of this Warrant. Notwithstanding the foregoing, except in the
case where an exercise of this Warrant is validly made pursuant to a Cashless Exercise), the Company’s failure to deliver
Shares to the Holder on

    	2

    	 

    

or prior to the later
of ((i) three (3) Trading Days after receipt of the applicable Exercise Notice and (ii) one (1) Trading Day after the Company’s
receipt of the Aggregate Exercise Price (or valid notice of a Cashless Exercise (such later date, the “Share Delivery
Deadline”) shall not be deemed to be a breach of this Warrant.

 

(b)              
Company’s Failure to Timely Deliver Securities. If the Company shall fail, for any reason or for no
reason, on or prior to the Share Delivery Deadline, if the Transfer Agent is not participating in the DTC Fast Automated Securities
Transfer Program, to issue and deliver to the Holder (or its designee) a certificate for the number of Shares to which the Holder
is entitled and register such Shares on the Company’s share register or, if the Transfer Agent is participating in the DTC
Fast Automated Securities Transfer Program, to credit the balance account of the Holder or the Holder’s designee with DTC
for such number of Shares to which the Holder is entitled upon the Holder’s exercise of this Warrant (as the case may be),
and if on or after such Share Delivery Deadline the Holder purchases (in an open market transaction or otherwise) shares of Common
Stock to deliver in satisfaction of a sale by the Holder of all or any portion of the number of shares of Common Stock issuable
upon such exercise that the Holder anticipated receiving from the Company (a “Buy-In”), then, in addition to all other
remedies available to the Holder, the Company shall, within three (3) Business Days after the Holder’s request and in the
Holder’s discretion, either (i) pay cash to the Holder in an amount equal to the Holder’s total purchase price (including
brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including, without
limitation, by any other Person in respect, or on behalf, of the Holder) (the “Buy-In Price”), at which point the Company’s
obligation to so issue and deliver such certificate (and to issue such shares of Common Stock) or credit the balance account of
such Holder or such Holder’s designee, as applicable, with DTC for the number of Shares to which the Holder is entitled upon
the Holder’s exercise hereunder (as the case may be) (and to issue such Shares) shall terminate, or (ii) promptly honor its
obligation to so issue and deliver to the Holder a certificate or certificates representing such Shares or credit the balance account
of such Holder or such Holder’s designee, as applicable, with DTC for the number of Shares to which the Holder is entitled
upon the Holder’s exercise hereunder (as the case may be) and pay cash to the Holder in an amount equal to the excess (if
any) of the Buy-In Price over the product of (A) such number of Shares multiplied by (B) the lowest Closing Sale Price of the Common
Stock on any Trading Day during the period commencing on the date of the applicable Exercise Notice and ending on the date of such
issuance and payment under this clause (ii). Nothing shall limit the Holder’s right to pursue any other remedies available
to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief
with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock (or to electronically
deliver such shares of Common Stock) upon the exercise of this Warrant as required pursuant to the terms hereof.

 

1.3.           
Cashless Exercise Right. In lieu of exercising this Warrant as specified in Article 1.2, Holder may from time
to time, following satisfaction of the Exercise Condition , in its sole discretion, exercise this Warrant in whole or in part and,
in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate
Warrant Price pursuant to Article 1.2, elect instead to receive upon such exercise the “Net Number” of shares of Common
Stock determined according to the following formula (a “Cashless Exercise”):

 

    	3

    	 

    

Net Number = (A x
B) - (A x C)

B

 

For purposes of the foregoing formula:

 

A= the total number of shares with respect to which this Warrant
is then being exercised.

 

B= the fair market value of each Share
shall be the average for the five Trading Days immediately prior to the date of determination thereof of the last reported sale
price regular way on each such day, or, in the case no such sale takes place on any such day, the average of the reported closing
bid and asked prices regular way of the shares of Common Stock on such day, in each case as quoted on the Principal Market, as
reported by Bloomberg or such other principal securities exchange or inter-dealer quotation system
on which the shares of Common Stock are then traded.

 

C= the Warrant Price then in effect for the applicable Shares
at the time of such exercise.

 

1.4.           
Delivery of Certificate and New Warrant. Promptly after Holder exercises or converts this Warrant, and, if
applicable, the Company receives payment of the aggregate Warrant Price, the Company shall deliver to Holder certificates for the
Shares acquired and, if this Warrant has not been fully exercised or converted and has not expired, a new Warrant representing
the Shares not so acquired. Holder shall be deemed to own and have all of the rights associated with any Shares or other securities
or property to which it is entitled pursuant to this Warrant upon the exercise or conversion of the Warrant in accordance with
this Article 1.

 

1.5.           
Replacement of Warrants. On receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant and in the case of loss, theft or destruction, on delivery of an indemnity agreement
reasonably satisfactory in form and amount to the Company or, in the case of mutilation on surrender and cancellation of this Warrant,
the Company shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor.

 

1.6.           
Treatment of Warrant Upon Acquisition of Company.

 

1.6.1.     
“Acquisition”. For the purpose of this Warrant, “Acquisition” shall mean the occurrence
of any of the following: (i) the consolidation of the Company with, or the merger of the Company with or into, another “person”
(as such term is used in Rule 13d-3 and Rule 13d-5 of the Exchange Act), or the sale, lease, transfer, conveyance or other disposition,
in one or a series of related transactions, of all or substantially all of the assets of the Company and its Subsidiaries taken
as a whole, or the consolidation of another “person” with, or the merger of another “person” into, the
Company, other than in each case pursuant to a transaction in which the “persons” that “beneficially owned”
(as such term is defined in Rule 13d-3 and Rule 13d-5 under the Exchange Act), directly or indirectly, the Voting Shares (as defined
below) of the Company immediately prior to the transaction “beneficially own”, directly or indirectly, Voting Shares
representing at least a majority of the total voting power of all outstanding classes of voting stock of the surviving or transferee
person; (ii) the adoption by the Company of a plan relating to the liquidation or dissolution of the Company; (iii) the
consummation of any

    	4

    	 

    

transaction (including, without limitation,
any merger or consolidation) the result of which is that any “person” becomes the “beneficial owner” directly
or indirectly, of more than 50% of the Voting Shares of the Company (measured by voting power rather than number of shares); or
(iv) the first day on which a majority of the members of the Company’s Board of Directors (the “Board”)
does not consist of Continuing Directors (as defined below). For the purposes of this Article 1.7.1, (i) “Voting Shares”
of any person shall mean capital shares or capital stock of such person which ordinarily has voting power for the election of directors
(or persons performing similar functions) of such person, whether at all times or only so long as no senior class of securities
has such voting power by reason of any contingency, and (ii) “Continuing Director” shall mean, as of any date of determination,
any member of the Board who (i) was a member of the Board on the Issue Date or (ii) was nominated for election or elected to the
Board with the approval of a majority of the Continuing Directors who were members of the Board at the time of such nomination
or election and who voted with respect to such nomination or election; provided that a majority of the members of the Board voting
with respect thereto shall at the time have been Continuing Directors.

 

1.6.2.     
Treatment of Warrant at Acquisition. In the event of an Acquisition, either (a) Holder shall exercise
or convert his Warrant in full with respect to all remaining Shares for which the Warrant is then exercisable and such exercise
or conversion will be deemed effective immediately prior to the consummation of such Acquisition or (b) if Holder elects not to
exercise or convert the Warrant, this Warrant will expire upon the consummation of such Acquisition. The Company shall provide
Holder with written notice of the foregoing (together with such reasonable information as Holder may request in connection with
such contemplated Acquisition giving rise to such notice), which is to be delivered to Holder not less than ten (10) days prior
to the closing of the proposed Acquisition.

 

1.7.           
Insufficient Authorized Shares. If at any time while the Warrant remains outstanding the Company does not
have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve for issuance
upon exercise of the Warrant at least a number of shares of Common Stock equal to 100% (the “Required Reserve Amount”)
of the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of the Warrant then outstanding,
then the Company shall immediately take all action necessary to increase the Company’s authorized shares of Common Stock
to an amount sufficient to allow the Company to reserve the Required Reserve Amount for the Warrant then outstanding.

 

Article
2.    ADJUSTMENTS TO THE SHARES.

 

2.1.           
Stock Dividends, Splits, Etc. If the Company declares or pays a dividend on the Shares payable in common stock of
the Company, or other securities, then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without cost
to Holder, the total number and kind of shares of common stock of the Company to which Holder would have been entitled had Holder
owned the Shares of record as of the date the dividend occurred. If the Company subdivides the Shares by reclassification or otherwise
into a greater number of shares or takes any other action which increases the amount of stock for which this Warrant is exercisable,
the number of Shares subject to the Warrant shall be proportionately increased and the Warrant Price shall be proportionately decreased.
If the outstanding shares are combined or consolidated, by

 

    	5

    	 

    

reclassification or otherwise, into a lesser
number of shares, the Warrant Price shall be proportionately increased and the number of Shares subject to the Warrant shall be
proportionately decreased.

 

2.2.           
Reclassification, Exchange, Combinations or Substitution. Upon any reclassification, exchange, substitution, or other
event that results in a change of the number and/or class of the securities issuable upon exercise or conversion of this Warrant
(other than an Acquisition which is subject to the provisions of Article 1.6), Holder shall be entitled to receive, upon exercise
or conversion of this Warrant the number and kind of securities and property that Holder would have received for the Shares if
this Warrant had been exercised immediately before such reclassification, exchange, substitution, or other event. The Company or
its successor shall promptly issue to Holder an amendment to this Warrant setting forth the number and kind of such new securities
or other property issuable upon exercise or conversion of this Warrant as a result of such reclassification, exchange, substitution
or other event that results in a change of the number and/or class of securities issuable upon exercise or conversion of this Warrant.
The amendment to this Warrant shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments
provided for in this Article 2 including, without limitation, adjustments to the Warrant Price and to the number of securities
or property issuable upon exercise of the new Warrant. The provisions of this Article 2.2 shall similarly apply to successive reclassifications,
exchanges, substitutions, or other events.

 

2.3.           
Rights Upon Distribution of Assets. If the Company shall declare or make any dividend or other distribution of its
assets (or rights to acquire its assets) to holders of shares of Common Stock (which dividend or other distribution has not already
been given to the Holder of the Warrant), by way of return of capital or otherwise (including, without limitation, any distribution
of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant
and prior to the Expiration Date, then, in each such case:

 

(a)any Warrant
Price in effect immediately prior to the close of business on the record date fixed for the determination of holders of shares
of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date,
to a price determined by multiplying such Warrant Price by a fraction of which (i) the numerator shall be the Closing Bid
Price of the shares of Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution
(as determined in good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and (ii) the denominator
shall be the Closing Bid Price of the shares of Common Stock on the Trading Day immediately preceding such record date; and

 

(b)the number
of Shares shall be increased to a number of shares equal to the number of shares of Common Stock obtainable immediately prior to
the close of business on the record date fixed for the determination of holders of shares of Common Stock entitled to receive the
Distribution multiplied by the reciprocal of the fraction set forth in the immediately preceding paragraph (a);

    	6

    	 

    

provided that in the event that the Distribution
is of shares of Common Stock(“Other Shares of Common Stock”) of a company whose common shares are traded on a national
securities exchange or a national automated quotation system, then the Holder may elect to receive a warrant to purchase Other
Shares of Common Stock in lieu of an increase in the number of Shares, the terms of which shall be identical to those of this Warrant,
except that such warrant shall be exercisable into the number of shares of Other Shares of Common Stock that would have been payable
to the Holder pursuant to the Distribution had the Holder exercised this Warrant immediately prior to such record date and with
an aggregate warrant price equal to the product of the amount by which the warrant price of this Warrant was decreased with respect
to the Distribution pursuant to the terms of the immediately preceding paragraph (a) and the number of Shares calculated in accordance
with the first part of this paragraph (b).

 

2.4.           
Other Adjustment Events. If any event occurs of the type contemplated by the provisions of this Article 2 but not
expressly provided for by such provisions, then the Company’s Board of Directors will make an appropriate adjustment in the
Warrant Price and the number of Warrant Shares so as to protect the rights of the Holder; provided that no such adjustment pursuant
to this Article 2.4 will increase the Warrant Price or decrease the number of Shares as otherwise determined pursuant to this Article
2.

 

2.5.           
No Impairment. Without the consent of the Holder, the Company shall not by amendment of its Certificate of Incorporation
or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue, or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this
Warrant by the Company, but shall at all times in good faith assist in carrying out of all the provisions of this Article 2 and
in taking all such action as may be necessary or appropriate to protect Holder’s rights under this Article against impairment.

 

2.6.           
Fractional Shares. No fractional Shares shall be issuable upon exercise or conversion of this Warrant and the number
of Shares to be issued shall be rounded down to the nearest whole Share. If a fractional share interest arises upon any exercise
or conversion of the Warrant, the Company shall eliminate such fractional share interest by paying Holder in cash equivalent to
the amount computed by multiplying the fractional interest by the fair market value of a full Share.

 

2.7.           
Certificate as to Adjustments. Upon each adjustment of the Warrant Price and Shares, the Company shall promptly notify
Holder in writing, and, at the Company’s expense, promptly compute such adjustment, and furnish Holder with a certificate
of its Chief Financial Officer, Corporate Secretary or a senior financial officer setting forth such adjustment and the facts upon
which such adjustment is based. The Company shall, upon written request, furnish Holder a certificate setting forth the Warrant
Price and Shares in effect upon the date thereof and the series of adjustments leading to such Warrant Price and Shares.

 

Article
3.    REPRESENTATIONS AND COVENANTS OF THE
COMPANY. The Company represents and warrants to the Holder as follows:

 

3.1.           
Representations and Warranties. The Company represents and warrants and covenants to the Holder as follows: all Shares
which may be issued upon the exercise of the

 

    	7

    	 

    

purchase right represented by this Warrant,
and all securities, if any, issuable upon conversion of the Shares, shall, upon issuance, be duly authorized, validly issued, fully
paid and nonassessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or under
applicable federal and state securities laws. The Company will at all times reserve and keep available, out of its authorized but
unissued share of Common Stock, solely for the purpose of providing the exercise or conversion of this Warrant, the aggregate number
of Shares issuable upon exercise or conversion of this Warrant. The Company will use its reasonable best efforts to ensure that
the Shares may be issued without violation of any law or regulation applicable to the Company or of any requirement of any securities
exchange applicable to the Company on which the Shares are listed or traded.

 

3.2.           
No Stockholder Rights. Except as provided in this Warrant, and other than with regard to shares of the Company’s
common stock acquired by Holder other than pursuant to the exercise of this Warrant, the Holder will not have any rights as a stockholder
of the Company until the exercise of this Warrant.

 

3.3.           
Charges, Taxes and Expenses. Issuance of certificates for Shares to the Holder upon the exercise or conversion of
this Warrant shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of
the issuance of such certificates, all of which taxes and expenses shall be paid by the Company.

 

Article
4.    REPRESENTATIONS, WARRANTIES OF THE
HOLDER. The Holder represents and warrants to the Company as follows:

 

4.1.           
Purchase for Own Account. This Warrant and the securities to be acquired upon exercise or conversion of this Warrant
by the Holder will be acquired for investment for the Holders account, not as a nominee or agent, and not with a view to the public
resale or distribution within the meaning of the Securities Act of 1933 (the “Securities Act”) and the Holder has no
present intention, and upon exercise or conversion will have no intention, of selling or engaging in any public distribution of
the same except pursuant to a registration or exemption. Holder also represents that the Holder has not been formed for the specific
purpose of acquiring this Warrant or the Shares.

 

4.2.           
Disclosure of Information. The Holder has received or has had full access to all the information it considers necessary
or appropriate to make an informed investment decision with respect to the acquisition of this Warrant and its underlying securities.
The Holder further has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions
of the offering of this Warrant and its underlying securities and to obtain additional information (to the extent the Company possessed
such information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to the
Holder or to which the Holder has access.

 

4.3.           
Investment Experience. The Holder understands that the purchase of this Warrant and its underlying securities involves
substantial risk. The Holder has experience as an investor in securities of companies in the development stage and acknowledges
that the Holder can bear the economic risk of such Holder’s investment in this Warrant and its underlying securities and
has such knowledge and experience in financial or business matters that the Holder is capable of

 

    	8

    	 

    

evaluating the merits and risks of its
investment in this Warrant and its underlying securities and/or has a preexisting personal or business relationship with the Company
and certain of its officers, directors or controlling persons of a nature and duration that enables the Holder to be aware of the
character, business acumen and financial circumstances of such persons.

 

4.4.           
Accredited Investor Status. The Holder is an “accredited investor” within the meaning of Regulation D
promulgated under the Securities Act.

 

4.5.           
The Securities Act. The Holder understands that this Warrant and the Shares issuable upon exercise or conversion
hereof have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends
upon, among other things, the bona fide nature of the Holder’s investment intent as expressed herein. The Holder understands
that this Warrant and the Shares issued upon any exercise or conversion hereof must be held indefinitely unless subsequently registered
under the Securities Act and qualified under applicable state securities laws, or unless exemption from such registration and qualification
are otherwise available. The Holder further understands that settlement of this Warrant is to be made in Shares and, for the elimination
of doubt, the fact that the Shares delivered on exercise of this Warrant will not be registered under the Securities Act (as defined
below) will not in any way require the Company to settle this Warrant otherwise than in Shares, including without limitation, that
there is no circumstance that would require the Company to settle this Warrant in cash.

 

Article
5.    MISCELLANEOUS.

 

5.1.           
Term. Following the satisfaction of the Exercise Condition described in Article 1.1, this Warrant will be exercisable
in whole or in part at any time and from time to time on or before the Expiration Date.

 

5.2.           
Legends. This Warrant and the Shares (and the securities issuable, directly or indirectly, upon conversion of the
Shares, if any) shall be imprinted with a legend in substantially the following form:

 

NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM
REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD
PURSUANT TO RULE 144 UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT 

 

    	9

    	 

    

OR
OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

5.3.           
Compliance with Securities Laws on Transfer. This Warrant and the Shares issuable upon exercise of this Warrant (and
the securities issuable, directly or indirectly, upon conversion of the Shares, if any) may not be transferred or assigned in whole
or in part without compliance with applicable federal and state securities laws by the transferor and the transferee (including,
without limitation, the delivery of investment representation letters and legal opinions reasonably satisfactory to the Company,
as reasonably requested by the Company). The Company shall not require Holder to provide an opinion of counsel if the transfer
is to any affiliate of the Holder, provided that any such transferee is an “accredited investor” as defined in Regulation
D under the Securities Act; provided, however, in any such transfer the transferee shall agree to be bound by the terms of this
Warrant as if an original holder hereof.

 

5.4.           
Notices. All notices and other communications from the Company to the Holder, or vice versa, shall be deemed delivered
and effective when given personally or mailed by first-class registered or certified mail, postage prepaid, at such address as
may have been furnished to the Company or the Holder, as the case may be (or on the first business day after transmission by facsimile),
in writing by the Company or such Holder from time to time. Effective upon receipt of the fully executed Warrant, all notices to
the Holder shall be addressed as follows until the Company receives notice of a change of address in connection with a transfer
or otherwise:

 

[investor notice
information]

 

Notice to the Company shall be addressed as follows until the
Holder receives notice of a change in address:

 

Amyris, Inc.

5885 Hollis Street, Suite 100

Emeryville, CA 94608

Attn: General Counsel

 

 

With a copy (which shall not constitute notice) to:

 

Fenwick & West LLP

801 California Street

Mountain View, CA 94041

Attn: Dan Winnike, Esq.

 

 

5.5.           
Waiver. This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in
writing signed by the parties against which enforcement of such change, waiver, discharge or termination is sought.

 

5.6.           
Automatic Conversion upon Expiration. In the event that, upon the Expiration Date, the fair market value of one Share
as determined in accordance with Article 1.4 above is greater than the Warrant Price in effect on such date and the Exercise Condition
has occurred prior to such date, then this Warrant shall automatically be deemed on and as of such date to be converted pursuant
to Article 1.3 above as to all Shares (or such other securities) for which it shall not previously have been exercised or converted,
and the Company shall promptly deliver a certificate representing the Shares (or such other securities) issued upon such conversion
to the Holder.

 

    	10

    	 

    

5.7.           
Counterparts. This Warrant may be executed in counterparts, all of which together shall constitute one and the same
agreement.

 

5.8.           
Amendment. This Warrant may be amended and the observance of any term of this Warrant may be waived only with the
written consent of the Company and the Holder.

 

5.9.           
Binding Effect. This Warrant shall be binding upon any successors or assigns of the Company.

 

5.10.       
Governing Law. This Warrant, and the provisions, rights, obligations, and conditions set forth herein, and the legal
relations between the parties hereto, including all disputes and claims, whether arising in contract, tort, or under statute, shall
be governed by and construed in accordance with the laws of the State of Delaware without giving effect to its conflict of law
provisions.

 

5.11.       
Dispute Resolution.This Warrant shall be subject to the dispute resolution provisions of the Exchange Agreement,
as such provisions are outlined in Section 9.6 thereof

 

Article
6.    CERTAIN DEFINITIONS.

 

“Bloomberg”
means Bloomberg Financial Markets.

 

“Closing Bid
Price” and “Closing Sale Price” means, for any security as of any date, the last closing bid price and last closing
trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins
to operate on an extended hours basis and does not designate the closing bid price or the closing trade price, as the case may
be, then the last bid price or last trade price, respectively, of such security prior to 4:00 p.m., New York time, as reported
by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the last
closing bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where
such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last
trade price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as
reported by Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg,
the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the “pink
sheets” by OTC Markets Group Inc. (formerly Pink Sheets LLC). If the Closing Bid Price or the Closing Sale Price cannot be
calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price,
as the case may be, of such security on such date shall be the fair market value as mutually determined by the Company and the
Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall
be resolved pursuant to Section 5.11. All such determinations to be appropriately adjusted for any stock dividend, stock split,
stock combination or other similar transaction during the applicable calculation period.

 

    	11

    	 

    

“Principal Market”
means The NASDAQ Global Select Market.

 

“Trading Day”
means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading
market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded;
provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange
or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on
such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange
or market, then during the hour ending at 4:00 p.m., New York time).

 

 

[Balance of Page Intentionally Left
Blank]

 

 

 

 

 

    	12

    	 

    

 

 

	 	 	“COMPANY”
	 	 	 	 
	 	 	Amyris, Inc.
	 	 	 	 
	 	 	 	 
	 	 	By:	 
	 	 	 	John Melo, Chief Executive Officer
	 	 	 	 
	 	 	 	 
	AGREED AND ACKNOWLEDGED:	 	 	 
	“HOLDER” 	 	 	 
	 	 	 	 
	Total Energies Nouvelles
        ActivitÉs USA	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	(Signature)	 	 	 
	 	 	 	 
	(Print Name)	 	 	 
	 	 	 	 
	(Title)	 	 	 
	 	 	 	 

 

 

    	 

    	 

    

Exhibit A

 

EXERCISE
NOTICE

 

TO BE EXECUTED
BY THE REGISTERED HOLDER TO EXERCISE THIS

WARRANT TO PURCHASE STOCK

 

AMYRIS,
INC.

 

The undersigned holder
hereby exercises the right to purchase _________________ of the shares of Common Stock (“Shares”) of Amyris,
Inc. a Delaware corporation (the “Company”), evidenced by Warrant to Purchase Stock No. _______ (the “Warrant”).
Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

 

1.Form of Exercise
Price. The Holder intends that payment of the Aggregate Exercise Price shall be made as:

 

		____________	a “Cash Exercise” with respect to _________________ Shares; and/or

 

		____________	a “Cashless Exercise” with respect to _______________ Shares.

 

2.Payment
of Exercise Price. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Shares to be
issued pursuant hereto, the Holder shall pay the Aggregate Exercise Price in the sum of $___________________
to the Company in accordance with the terms of the Warrant.

 

3.Delivery
of Shares. The Company shall deliver to Holder, or its designee or agent as specified below, __________ Shares
in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:

 

[_]Check here if
requesting delivery as a certificate to the following name and to the following address:

 

	Issue to:	 	 
	 	 	 
	 	 	 

 

  [_]Check here if requesting delivery by Deposit/Withdrawal at Custodian as follows:

 

	DTC Participant:	 	 
	DTC Number:	 	 
	Account Number:	 	 

 

    	14

    	 

    

 

 

	Date: _____________ __,  _____	 
	 	 	 	 	 
	 	 	 	 	 
	Name of Registered Holder	 
	 	 	 	 	 
	 	 	 	 	 
	By:	 	 	 	 
	 	Name:	 		 
	 	Title:	 		 
	 	 	 	 	 
	 	 	 	 	 
	 	Tax ID:	 	 	 
	 	Facsimile:	 	 	 
	 	E-mail Address:	 	 	 

 

  

 

    	15

    	 

    

Schedule A

 

Warrants Issued by Registrant

 

 

	Purchaser	Warrant Shares	Certificate Number
	Foris Ventures, LLC	961,538	W-1
	
        Wolverine Flagship Fund

        Trading Limited
	128,205	W-2
	Nomis Bay Ltd.	64,102	W-3
	
        Total Energies Nouvelles

        Activités USA
	128,205	W-4
	
        Connective Capital I

        Master Fund, LTD
	64,102	W-5
	
        Connective Capital

        Emerging Energy QP, LP
	32,051	W-6
	Naxyris S.A.	224,359	W-7

 

 

 

16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}]]